Location: Home
  • search
  • go
  • Relate News
  • 1/11/2017Chinese AI Company Plans to Mine Health Data Faster Than Rivals
  • 1/11/2017Bioworld: China-U.S. Biopharma Players Look on Bright Side for 2017
  • 1/11/2017Sanofi China Wins Double Recognition for Its CSR Efforts
  • 1/11/2017Trump Challenges Pharma Outsourcing, Unnerving Drug Makers with Manufa...
  • 1/11/2017CFDA Withdraws Approvals of 147 Drug Products
  • 1/11/2017CFDA Solicits Public Comments on Naming Principle of Formulated TCMs
  • 1/11/2017Demographic Convergence And The Coming Chinese Healthcare Explosion
  • 1/11/2017Chi-Med Initiates HMPL-523 Clinical Trials in Hematological Cancer in ...
  • 1/11/2017MilliporeSigma Expands Biodevelopment Centers to the U.S. and China
  • 1/11/2017USTR Releases 2016 Report on China's WTO Compliance Highlighting Pharm...
  • 1/10/2017U.S. DEA Opens China Office to Help Fight Synthetic Drug Trade
  • 1/10/2017Kite and Fosun Form Chinese JV for Autologous T-Cell Therapies to Trea...
  • 1/10/2017Data Snapshot - Review of Chinese Drug Registration Applications 2010-...
  • 1/10/2017State Council Issues China's 13th Five Year Plan for Healthcare Reform
  • 1/10/2017CDE Seeks Public Comments on Proposed Guideline for Chemical Drug Manu...
  • 1/9/2017AbbVie, Genomics Medicine and WuXi NextCODE Announce Landmark Populati...
  • 1/9/2017BeiGene Announces First Patient Dosing in China Phase I Trial for Anti...
  • 1/9/2017Valeant To Sell Dendreon To Sanpower Group for $819.9M in Cash
  • 1/9/2017China’s Cancer Patients Gamble on Gray Market
  • 1/9/2017Fosun Pharma Unveils Plan to Offer Innovative Options for Battle again...
  • 1/9/2017NHFPC Lays Out Major Tasks for 2017 at National Health Conference
  • 1/9/2017China Introduces Implementation Rule for "Two Invoice System"...
  • 1/6/2017CFDA Announces Overview of Drug Applications under MAH Trial
  • 1/6/2017Jiangsu Nhwa Pharma Licenses China Rights of NVX-408 from NuvOx Pharma
  • 1/6/2017Ambrx and MabSpace Biosciences to Collaborate on Novel Antibody Drug C...
  • 1/5/2017TOT Biopharm and Lee's Pharma Enters Licensing Agreement on mAb Drug T...
  • 1/5/2017Drug Kickbacks, the Incurable Disease of Public Hospitals in China
  • 1/5/2017Big Data Policy And Legal Issues In The Healthcare Industry
  • 1/5/2017PhIRDA Joins IFPMA as A Formal Member
  • 1/4/2017US FDA Grants Orphan Drug Designation to Yisheng Biopharma's PIKA Rabi...
  • Page:379/778 Total number of articles:23324: [First][<<] [377] [378] [379] [380] [381] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group